Ligand (LGND) Breakout! Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout!

LGND 192.28

+1.2%

3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: celeryroot.com who wrote (24416)	8/12/1998 2:08:00 PM
From: Henry Niman	of 32384

Per LGND's 1997 (and earlier) Annual Reports, Lloyd Flanders is (was) a "Senior Vice President, Preclinical Development and R&D Project Manager". He is no longer with Ligand and I believe that he left right after the delayed NDA filing for topical Panretin. I suspect that there may have been a relationship the delay of the filing, and his departure, but I have no details. I did ask SA last week about his recent sale of stock, and as I suspected, she confirmed that he was no longer with LGND and had to exercise options within 90 days, hence the sale of some (all?) of his holdings.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next